pioglitazone has been researched along with Degenerative Diseases, Central Nervous System in 4 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Herein, we have studied the potential of nanomedicine to prepare a single platform based on mesoporous silica nanoparticles (MSNs) for the treatment of an ALS animal model with a cocktail of agents such as leptin (neuroprotective) and pioglitazone (anti-inflammatory), which have already demonstrated promising therapeutic ability in other neurodegenerative diseases." | 8.12 | Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone. ( Cabrera-Pinto, M; Díaz-García, D; Díaz-Sánchez, M; Fernandez-Martos, CM; Ferrer-Donato, Á; Gómez-Ruiz, S; Méndez-Arriaga, JM; Prashar, S, 2022) |
| " Herein, we have studied the potential of nanomedicine to prepare a single platform based on mesoporous silica nanoparticles (MSNs) for the treatment of an ALS animal model with a cocktail of agents such as leptin (neuroprotective) and pioglitazone (anti-inflammatory), which have already demonstrated promising therapeutic ability in other neurodegenerative diseases." | 4.12 | Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone. ( Cabrera-Pinto, M; Díaz-García, D; Díaz-Sánchez, M; Fernandez-Martos, CM; Ferrer-Donato, Á; Gómez-Ruiz, S; Méndez-Arriaga, JM; Prashar, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackburn, JK | 1 |
| Jamwal, S | 1 |
| Wang, W | 1 |
| Elsworth, JD | 1 |
| Díaz-García, D | 1 |
| Ferrer-Donato, Á | 1 |
| Méndez-Arriaga, JM | 1 |
| Cabrera-Pinto, M | 1 |
| Díaz-Sánchez, M | 1 |
| Prashar, S | 1 |
| Fernandez-Martos, CM | 1 |
| Gómez-Ruiz, S | 1 |
| Basagni, F | 1 |
| Di Paolo, ML | 1 |
| Cozza, G | 1 |
| Dalla Via, L | 1 |
| Fagiani, F | 1 |
| Lanni, C | 1 |
| Rosini, M | 1 |
| Minarini, A | 1 |
| Thal, SC | 1 |
| Neuhaus, W | 1 |
1 review available for pioglitazone and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
The blood-brain barrier as a target in traumatic brain injury treatment.
Topics: Blood-Brain Barrier; Brain Edema; Brain Injuries; Cell Hypoxia; Humans; Hypoglycemic Agents; Inflamm | 2014 |
3 other studies available for pioglitazone and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Pioglitazone transiently stimulates paraoxonase-2 expression in male nonhuman primate brain: Implications for sex-specific therapeutics in neurodegenerative disorders.
Topics: Animals; Aryldialkylphosphatase; Brain; Female; Mitochondria; Neurodegenerative Diseases; Neuroprote | 2022 |
Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone.
Topics: Amyotrophic Lateral Sclerosis; Animals; DNA-Binding Proteins; Leptin; Mice; Mice, Transgenic; Nanopa | 2022 |
Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected Targets.
Topics: Antioxidants; Humans; Monoamine Oxidase; Neurodegenerative Diseases; NF-E2-Related Factor 2; Oxidati | 2023 |